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The nucleus accumbens 5-HTR4-CART pathway ties
anorexia to hyperactivity
A Jean1,2,3,4,9, L Laurent1,2,3,9, J Bockaert1,2,3, Y Charnay5, N Dusticier6, A Nieoullon6, M Barrot7, R Neve8 and V Compan1,2,3,4
In mental diseases, the brain does not systematically adjust motor activity to feeding. Probably, the most outlined example is the
association between hyperactivity and anorexia in Anorexia nervosa. The neural underpinnings of this ‘paradox’, however, are
poorly elucidated. Although anorexia and hyperactivity prevail over self-preservation, both symptoms rarely exist independently,
suggesting commonalities in neural pathways, most likely in the reward system. We previously discovered an addictive
molecular facet of anorexia, involving production, in the nucleus accumbens (NAc), of the same transcripts stimulated in
response to cocaine and amphetamine (CART) upon stimulation of the 5-HT4 receptors (5-HTR4) or MDMA (ecstasy). Here, we
tested whether this pathway predisposes not only to anorexia but also to hyperactivity. Following food restriction, mice
are expected to overeat. However, selecting hyperactive and addiction-related animal models, we observed that mice lacking
5-HTR1B self-imposed food restriction after deprivation and still displayed anorexia and hyperactivity after ecstasy. Decryption of
the mechanisms showed a gain-of-function of 5-HTR4 in the absence of 5-HTR1B, associated with CART surplus in the NAc and
not in other brain areas. NAc-5-HTR4 overexpression upregulated NAc-CART, provoked anorexia and hyperactivity. NAc-5-HTR4
knockdown or blockade reduced ecstasy-induced hyperactivity. Finally, NAc-CART knockdown suppressed hyperactivity upon
stimulation of the NAc-5-HTR4. Additionally, inactivating NAc-5-HTR4 suppressed ecstasy’s preference, strengthening the
rewarding facet of anorexia. In conclusion, the NAc-5-HTR4/CART pathway establishes a ‘tight-junction’ between anorexia and
hyperactivity, suggesting the existence of a primary functional unit susceptible to limit overeating associated with resting
following homeostasis rules.
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Introduction
In mental diseases (for example, depression, anxiety, eating
disorders), the brain does not systematically adjust energy
expenditures to intakes, as highlighted by the ‘paradoxical’
association between restrictive diet and motor hyperactivity in
Anorexia nervosa.1–3 Here, we set out to study potential
neural underpinnings of this apparent homeostatic failure. We
reasoned that if at least one single molecular pathway triggers
both anorexia and motor hyperactivity, its abnormal activation
could prevail over homeostasis rules. In this situation,
interpreting motor hyperactivity as an ‘intention’ of patients
with anorexia could be challenged because their motor
hyperactivity would be anorexia-dependent. In contrast, if
two parallel and different pathways trigger anorexia on one
hand, and motor hyperactivity on the other hand, a complex
coincidence of two parallel impairments in both the feeding
and motor neural networks could be in cause.
Among the cumulative neural events related to anorexia, as
in most eating disorders, altered 5-HT volume transmission4 is
at the forefront of investigations.5 With exceptions, regardless
stimulation of 5-HT1A and 5-HT2B receptors (5-HTR1A,
5-HTR2B) in the hypothalamus,
6 increased activity of 5-HT
transmission in brain following treatments classically reduces
feeding and body weight.7 For instance, the 3,4-N-methyle-
nedioxymethamphetamine (MDMA, ecstasy) diminishes
feeding in rodents and humans, and enhances motor
hyperactivity.8–11
The hypothalamus appears central in regulating feeding
behavior,12 but motivation disorders related to self-imposed
food restriction despite energy demand (anorexia) may
involve disturbances in the nucleus accumbens (NAc),7,13,14
a brain structure involved in reward and feeding.15–18
Considering the ability of 5-HT4 receptors (5-HTR4) knockout
(KO) mice to better resist stress-induced anorexia, we
detected a first example of an addictive molecular facet of
anorexia.14,19 Indeed, stimulating NAc-5-HTR4, as MDMA,
provokes anorexia only if production of the same transcripts
stimulated in response to cocaine and amphetamine (CART)
is increased in the NAc.14
We investigated, here, whether the NAc-5-HTR4/CART
molecular pathway triggers not only anorexia but also motor
hyperactivity. To address this possibility, we used (i) an
addiction- and hyperactive-related animal model: the
5-HTR1B KO (KO1B) mice, (ii) the ability of MDMA to mimic
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both anorexia and hyperactivity and (iii) siRNA- and viral-
mediated knockdown and surplus strategies combined to
molecular and behavioral techniques.
Methods
Animals. Male KO1B, KO4 and control mice (WT1B, WT4)
from heterozygous breeding (129/SvTer)19,20 were housed
with food and water available ad libitum.14 Male WT 129/
SvPas mice were used when KO mice were not required. All
experiments were performed on mice aged of 4–6 months,
except a set, aged of 2 months (Figures 1a and b), following
the Guide for Care and Use of Laboratory Animals
(authorization n1 21CAE011) (see Supplementary
Information).
Surgery. As described in detail,14 a sterile 26-gauge
stainless steel guide was unilaterally implanted in the left
shell NAc for infusing 1 ml of each compound in freely moving
mice (1ml/min). The localization of the injection site was
assessed in each mouse (see Supplementary Information).
Pharmacological and nucleic acid treatments in freely
moving mice. As established,11,14,21 MDMA (10 mg kg 1,
Sigma, L’Isle d’Abeau Chesnes, Saint-Quentin-Fallavier,
France) and selective dose of 5-HTR4 antagonist, RS39604
(0.5 mg kg 1, Tocris, Ellisville, USA) were dissolved in NaCl
(9%) before acute intraperitoneal (i.p.) administration. The
5-HTR4 agonist BIMU8 (Tocris, Ellisville, USA) and RS39604
was injected in the NAc at selective dose (4 10 4 mgml 1).
Acute injection in the NAc of (i) double-stranded siRNA-5-
HTR4 (si5-HTR4), siCART provoked 5-HTR4 and CART
downregulation compared with siRNA controls (siCt:
0.05mgml 1), respectively; and of (ii) viral vector of mHtr4
gene (HSV-5-HTR4; 10
7 infectious units per ml, 1ml min 1),
an overexpression of 5-HTR4 compared with HSV-LacZ
construct (see Supplementary Information).
Biochemical analyses. As described,22 the levels of 5-HT
and 5-HIAA were evaluated in brain tissue samples contain-
ing the NAc (þ 1.6 mm), striatum (þ 1.0 mm), dorsal
hippocampus ( 2.2 mm) and amygdala ( 3.2 mm from
the bregma)23 of WT4 and KO4 mice sacrificed 5 min after the
end of the open-field session. As reported in detail,14,19
receptor autoradiography was performed using
(125I)SB207710 and (3H)GR113808, two specific 5-HTR4
antagonists (see Supplementary Information).
Quantitative Real-Time PCR. Mice were sacrificed 3-h
after the different treatments and NAc (2 1.2 mm3) and
hypothalamus (3.9 mm3) were micro-dissected from 1 mm-
thick sections to treat total mRNA and treat complementary
DNA in reactions containing CART or 5-HTR4 primers, as
described in detail.14,24
Activity. Naive or feeding-tested mice were tested in the
open-field19 after i.p. administration of NaCl or MDMA
combined with (i) i.p. administration of RS39604 in KO1B,
Figure 1 Anorexia-like symptoms in KO1B mice are treated with RS39604, a 5-HTR4 antagonist. (a–c) Total food intake of WT1B and KO1B mice following (a, b) 3 days of
diet ( 20%), over 24-h after NaCl or RS39604 (0.5 mg/kg) and (c) 24 h of 100% food deprivation, over 1 h after NaCl, MDMA (10 mg kg 1, RS39604 alone, or combined with
MDMA. (d-f) Total distance traveled (d, e) every 5 min (f) over 110-min after MDMA combined with RS39604 or not compared with NaCl. Data are means±s.e.m.; n¼ 7–11
per group of mice treated with i.p. administration of each compound. *Po0.05, **Po0.01; yPo0.05, yyPo0.01, yyyPo0.001; $Po0.05, $$$Po0.001 compared with WT1B,
NaCl and MDMA, respectively; #Po0.05, ##Po0.01 genotype and treatment interaction.
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KO4, WT1B and WT4 mice and intra-accumbal infusion of (ii)
si5-HTR4, RS39604, siCt (or NaCl) as controls in WT 129 Sv/
Pas mice and (iii) HSV-5-HTR4, BIMU8 combined or not with
siCART, compared with controls (NaCl, HSV-LacZ, siCt) in
WT 129 Sv/Pas mice. Ten min after RS39604 injection, 3 h
after injection of the siRNAs or BIMU8, or 1 day after viral
infection, the traveled path length was monitored.19
Feeding tests. Classic feeding paradigms11,19 were used in
fed mice or, following (i) 100% food deprivation for 24 h or (ii)
20% food-restriction for 3 consecutive days. Four days
before the experiments, mice were isolated in metabolic
cages for baseline period with ad libitum access to food
(pellet form, 16.5% crude proteins, 3.6% crude fat, 4.6%
crude fibers, 5.2% ash). Food-deprived WT1B and KO1B mice
were treated with i.p. administration of NaCl or RS39604
combined or not with MDMA. WT129Sv/Pas mice received
acute infusion of HSV-5-HTR4 or HSV-LacZ in the NAc and
were 20% food-deprived for 3 days. The amount of food
consumed (not include the spillage) was measured with 1 mg
precision.
Place conditioning paradigm. An unbiased place condi-
tioning protocol was adapted.25 Mice received i.p. adminis-
tration of NaCl, MDMA combined or not with RS39604, or
injection in the NAc of NaCl or RS39604, 30 min before being
confined to a single conditioning zone on alternate condition-
ing days. A preference score is the difference between times
spent by each mouse in the MDMA-, NaCl-, RS39604-, or
MDMA plus RS39604-paired zone during the preconditioning
and testing phases (see Supplementary Information).
Statistical analysis. Data obtained in multiple sessions
over time (food intake, locomotion) were analyzed using
repeated measures analysis of variance (STATVIEW 5
software, SAS Institute Inc., San Francisco, CA, USA).
When effects of independent variables (treatment, genotype,
time), or interactions were significant, one-way analysis of
variance (treatment, time or genotype) analyses were per-
formed. For multiple comparisons, the Scheffe´ F-test was
used. Differences with Po0.05 were considered significant.
Results
KO1B self-imposed food restriction following restriction
and displayed hyperactivity: Anorexia-like symptoms
still observed after MDMA. Considering the influence of
5-HT in the potential rewarding facet of anorexia,14 we tested
whether an animal model predisposes to abuse of cocaine,
and to be hyperactive persists to self-restrict following food
restriction. Young KO1B and WT1B mice (2 months) were
then selected26,27 and deprived of 20% of their normal food
rations for 3 days in their home cages (means±s.e.m. of
normal food ration for 24 h expressed in g. in WT1B:
4.80±0.09 vs KO1B: 4.82±0.16). When food was reintro-
duced and available ad libitum after the diet period, WT1B
mice were eating more than their normal meal size
(Figure 1a). This rebound in food intake was reduced in
KO1B mice that even ate less than their predeprivation food
ration after 3 days ad libitum (Figure 1a). Moreover, KO1B
mice did display increased locomotion compared with saline-
injected WT1B mice (Figures 1d and f), as reported.
26,28
Following MDMA in KO1B mice, anorexia (Figure 1c), and
hyperactivity although reduced (Figures 1e and f), are still
observed, consistently with a previous study using a 5-HTR1B
antagonist (GR127935).11
The absence of 5-HTR1B then predisposes to anorexia-like
symptoms in challenge situations. We next tested whether
this predisposition requires 5-HTR4.
Inactivating 5-HTR4 in KO1B mice suppressed their
anorexia and hyperactivity. Selective inactivation of
5-HTR4
14 in food-restricted KO1B mice restores adaptive
feeding and motor responses because the mutant did not
self-restrict (Figure 1b) and were not hyperactive anymore
(Figures 1d and f). Inactivating 5-HTR4 suppressed anorexia
(Figure 1c) and hyperactivity (Figures 1e and f) induced by
MDMA in KO1B compared with NaCl-treated KO1B mice.
Identical dose of antagonist only reduced both effects in
WT1B mice (Figures 1c–f), suggesting a gain-of-function of
5-HTR4 owing the absence of 5-HTR1B. To ensure this issue,
we first assessed whether the gene defective-mutation of
5-HTR4 reduce hyperactivity induced by novelty and MDMA.
This is the observed effect (Supplementary Figure S1). We
then evaluated the density of 5-HTR4 sites and mRNA in the
brain of KO1B mice.
Only the NAc of KO1B mice over-expressed both 5-HTR4
and CART whereas its hypothalamus over-expressed
5-HTR4 but down-expressed CART. Among brain areas
examined (Supplementary Table S1), 5-HTR4 density
(Figure 2a) and mRNA content (Figure 2b) were higher in
the NAc and hypothalamus of KO1B compared with WT1B
mice. The levels of CART mRNA were higher in the NAc and
weaker in the hypothalamus of KO1B compared with WT1B
mice (Figures 2c and d). Because CART in both the NAc and
hypothalamus decreases feeding,14,29 its opposite changes
could underlie the adequate feeding behavior of KO1B mice in
baseline conditions.11,30 Accordingly, the ability of KO1B mice
to self-restrict of food might depend on excessive NAc-5-
HTR4. We next focused on the NAc because additionally,
marked increases in 5-HT metabolism were not detected in
the NAc of KO4 mice following the open-field session
(Supplementary Table S2). To avoid bias of adaptive
changes in KO mice and determine whether a 5-HTR4
surplus within the NAc triggers both anorexia and hyper-
activity, mHtr4 gene (HSV-5-HTR4) was transferred in the
NAc of WT mice.
Overexpression of 5-HTR4 in the NAc ties anorexia to
hyperactivity. Injecting HSV-5-HTR4 in the NAc of WT mice
increased the density of NAc-5-HTR4 at 54-h postinjection
(Figure 3a). The NAc-5-HTR4 mRNA content was still higher
at 72 h than in control mice (HSV-LacZ), with the highest
level observed at 30-h postinjection (Figure 3b). Consis-
tently, CART mRNA content at 72-h postinjection was
increased in the NAc (Figure 3c) and unchanged in the
hypothalamus (Figure 3c) following injection of HSV-5-HTR4
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in the NAc, compared with controls. Stimulating NAc-5-HTR4
also increases CART mRNA content in the NAc but not in the
hypothalamus.14
The feeding and motor behaviors were then analyzed. At
24-h postinjection, overexpressing NAc-5-HTR4 decreased
feeding (35%, Figure 3d) and enhanced motor activity (148%,
Figure 3e). HSV-5-HTR4 mice did further self-restrict after
restriction compared with controls (Figure 3f), mimicking
feeding responses of KO1B mice, following 20% of their
normal food rations for 3 days.
Subsequently, NAc-5-HTR4 surplus increased CART,
decreased feeding and increased motor activity. To circum-
vent the ectopic expression after viral vector injection,
potential conclusion was ensured using pharmacological
and RNA interference approaches, as we established.14
In the NAc, stimulation of 5-HTR4 increases motor
activity, and their blockade reduces hyperactivity. The
distance covered in the open-field is enhanced following
stimulation of NAc-5-HTR4 with a specific dose of BIMU8, an
agonist (198%), and unchanged following their specific
blockade with antagonist or RNA interference (si5-HTR4)
infused in the NAc (Figures 4a and b). In contrast,
antagonism or knockdown of NAc-5-HTR4 reduced hyper-
activity induced by i.p. administration of MDMA (Figure 4a).
CART knockdown in the NAc inhibits stimulating NAc-5-
HTR4-induced motor hyperactivity. We next examined
whether CART in the NAc mediates the motor effects of
BIMU8, a 5-HTR4 agonist. Blocking CART with RNA
interference (siCART) in the NAc suppressed the motor
hyperactivity induced by stimulation of 5-HTR4 (Figure 4b).
We finally tested whether MDMA’s preference requires
5-HTR4 because a rewarding effect could prevail over self-
preservation.
Inactivating 5-HTR4 suppressed MDMA’s preference in
WT and reduced it in KO1B mice. Using the conditioned
place preference test, we found that The KO1B mice
displayed a higher preference for MDMA than WT1B mice
(Figure 5a), which is reduced after i.p. administration of a
5-HTR4 antagonist (Figure 5a). An absence of preference for
MDMA is further shown when 5-HTR4 is locally inactivated in
the NAc of adult WT4 mice (Figure 5b).
Figure 2 KO1B mice over-expressed 5-HTR4 and CART in the NAc. (a) The density of 5-HTR4 binding site ((
3H)GR113808) of KO1B compared with WT1B mice following
analyses of 3–6 brain frontal sections per structure level and per mouse (n¼ 5). (b) 5-HTR4 and (c) CART mRNA content in the NAc and hypothalamus (Hyp) of KO1B (n¼ 6)
and WT1B mice (n¼ 7). (d) In situ hybridization of CART mRNA (scale bar: NAc, 100mm; Hyp, 1 mm; arrows point to changes). Data are means±s.e.m.; and Po0.05
difference between the NAc and Hyp in either WT1B or KO1B mice; *Po0.05, **Po0.01 compared with WT1B.
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Discussion
Over the last ten decades, parallel neural systems have been
described to control feeding and motor behaviors. Here, we
found a first example of a molecular signal foul-up between
motor hyperactivity and anorexia, providing a common path-
way of control. This would lead us to reconsider the belief that
patients with anorexia nervosa intend to accelerate their
weight loss with over-exercise3,31–33 because hyperactivity
could be more inevitable than deliberate.
These findings strengthen the addictive facet of restrictive
diet, now also observed in mice, dispossessed of 5-HTR1B
and/or endowed of a NAc-5-HTR4 surplus because they
self-restrict despite an upstream ‘starter’ period of restrictive
diet, believed to trigger ‘spiral’ restrictions in humans.34
Animal models of anorexia-like symptoms predisposition,
identified herein, mimic the activity-based anorexia rat
model,35 and are to the best of our knowledge, unique. It is
noteworthy to observe that KO1B mice persist to self-restrict
their intake of food. Excluding adaptive mechanisms, KO1B
mice would be expected to consume a higher amount of food
because stimulating 5-HTR1B decreases feeding.
11,36 This
phenotype is apparently not related to the reduced activity of
5-HTR2C in KO1B mice
37 because stimulating 5-HTR2C
decreases feeding.38 In contrast, present results showed a
Figure 3 Overexpression of 5-HTR4 in the NAc ties anorexia to hyperactivity in WT mice. (a) Increased density of NAc-5-HTR4 binding site ((
125I)SB207710) in the NAc (1)
but not in nearness structure (2: ventral pallidum) observed on transverse brain sections from mice infused in the NAc with HSV-5HTR4 compared with control (HSV-LacZ) and
sacrificed 54-h postinfusion. Circles highlight changes and delineate the injection site in a brain section stained with hematoxylin (right upper panel), indicating an absence of
damage tissue. (b) NAc-5-HTR4 mRNA content increased after infusion, in the NAc, of HSV-5-HTR4 (n¼ 8 mice for each time point for both conditions). (c) NAc- and
Hyp-CART mRNA content 72 h after injection of HSV-5-HTR4 or HSV-LacZ. (d, f) Total food intake in (d) fed and (f) food-deprived (3 days, 20%) mice (d) 24 h and (f) 3 days
after infusion, in the NAc, of HSV-5-HTR4 (n¼ 6) or HSV-LacZ (n¼ 5). (e) Total distance traveled. Data are means±s.e.m.; yPo0.05, yyPo0.01, yyyPo0.001 compared to
HSV-LacZ; &Po0.05 differences between the NAc and hypothalamus; ###Po0.001 interaction between time and treatment.
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gain-of-function of 5-HTR4, consistent with the inhibitory
influence of 5-HTR4 on feeding.
14,19 Also, inactivating
5-HTR4 suppressed motor hyperactivity in KO1B mice,
consistently with the weaker efficacy of MDMA to enhance
locomotion in KO4 and 5-HTR4 antagonist-treated WT mice.
The surplus of 5-HTR4 in KO1B mice further suggests a
negative 5-HTR1B control of 5-HTR4 accordant with series of
results; (i) The decreased levels of NAc-5-HT in KO1B mice
39
because lesion of 5-HT neurons, though in rats, upregulates
5-HTR4 in brain areas including the NAc;
40 (ii) The 5-HTR1B
and 5-HTR4 location does not overlap (for example. in the
striatum,40,41 on 5-HT neurons24,42,43) likely related to their
common binding to p11;44,45 (iii) KO1B mice are hyperactive
and less ‘anxious’46 while KO4 mice are hypoactive and more
‘anxious’ under stress.19,47
Molecular events for driving self-restriction and motor hyper-
activity are detected in the NAc. The NAc-5-HTR4 surplus induced
sustained anorexia and motor hyperactivity, mimicking the
molecular and behavioral phenotypes of KO1B mice
(NAc-5-HTR4/CART surplus, anorexia, hyperactivity). Similarly,
stimulation of NAc-5-HTR4 decreases feeding
14 and increases
locomotion.
As difference in feeding responses to activation of 5-HTR
subtypes, stimulation of 5-HTR1B, 5-HTR2C, 5-HTR1-7 and
5-HTR6 in the NAc did not change locomotion in basal
conditions, however, in rats (Supplementary Figure S2).48–50
Likewise, blocking or silencing NAc-5-HTR4 did not change
locomotion but suppressed hyperactivity induced by MDMA,
in tune with the effect of the whole blockade of 5-HTR1B,
5-HTR2B and 5-HTR2C.
28,51–54 In rats, inactivating NAc-5-
HTR4 did not however, alter hyperactivity after MDMA,
50
suggesting differences between doses and species.55,11
To the end, stimulating NAc-5-HTR4 in mice not only
triggers anorexia but also hyperactivity, consistent with
opposite changes in feeding and locomotion detected only
in KO4 mice, compared with other 5-HTR KO mice
(Supplementary Figure S2).
The present study extends observations at a molecular
level. Ectopic (viral mHtr4 gene) or ‘physiological’ surplus
of NAc-5-HTR4 in KO1B mice upregulates NAc-CART,
Figure 4 Motor hyperactivity induced by stimulation of NAc-5-HTR4 requires CART. (a) Total distance traveled over 110 min after i.p. administration of NaCl or MDMA plus
an intra-accumbal infusion of control solution (NaCl or si5-HTR4 control: siCt), si5-HTR4, 5-HTR4 antagonist (RS39604) and (b) of WT mice after an intra-accumbal infusion of
controls, 5-HTR4 agonist (BIMU8), siCART or BIMU8 plus siCART. Data are means±s.e.m.; n¼ 5–10 mice per each group, treated with MDMA (10 mg Kg 1), siRNA
(0.05mg ml 1), viral vector (107 infectious units per ml), RS39064 or BIMU8 (4 10 4mgml 1). yyPo0.01, $$Po0.01, &&&Po0.001 compared to controls, MDMA and
BIMU8, respectively.
Figure 5 MDMA’s preference involves 5-HTR4 in an unbiased conditioned place preference test. (a) Score preference in WT1B and KO1B mice treated with i.p.
administration of NaCl, MDMA (10 mg kg 1), combined or not with RS39604 (0.5 mg kg 1) and (b) in WT mice treated with i.p. administration of NaCl or MDMA
(10 mg kg 1) plus intra-accumbal infusion of NaCl or RS39604 (4 10 4 mg ml 1). Data are means±s.e.m.; n¼ 7–9 mice per group. *Po0.05 compared to WT1B;
yPo0.05, yyPo0.01 compared with NaCl; $Po0.05, $$Po0.01 compared with MDMA.
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as observed following stimulation of NAc-5-HTR4.
14
A final experiment in our series bore out our hypothesis
because NAc-CART knockdown suppressed not only
anorexia14 but also motor hyperactivity induced by NAc-5-
HTR4 stimulation. In addition, locomotion is unchanged
following CART peptide56 or siCART injection in the NAc.
Identifying the cellular origin of this action would require long
investigations. Nonetheless, NAc-neurons containing
GABA projecting to the lateral hypothalamus express
CART14,57–59 and might also express 5-HTR4
(Supplementary Figure S2).24,40,43,58 Injecting si5-HTR4 in
the NAc decreased the density of 5-HTR4 not only in the NAc
but also in the lateral hypothalamus ( 14%, not illustrated).
The 5-HTR4 located on these neurons may influence
feeding and locomotion (Supplementary Figure S2) because
the lateral hypothalamus, in relation to the NAc, controls
feeding and its stimulation enhances locomotion in the
activity-based rat model for anorexia nervosa.15,60–63 Colo-
calization of 5-HTR4/CART is more conceivable than in two
different neuronal populations, considering the 5-HTR4 con-
trol of CART within the NAc via a cAMP/PKA signaling
pathway.14 Interestingly, it appears that 5-HT receptors
expressed in the different subnuclei of the hypothalamus
(arcuate nucleus: 5-HTR1B, 5-HTR2C) may provoke an
anorexia associated or not with different changes in locomo-
tion, as induced by fenfluramine64,65 that increase,51
decrease66,67 or does not modify locomotion68 while,
5-HTR4 likely located on the afferent neurons of the NAc to
the lateral hypothalamus may provoke an anorexia associated
with motor hyperactivity.
Finally, the present study suggests that activation of the
NAc-5-HTR4 promotes a rewarding effect because (i) mice
with NAc-5-HTR4 surplus limit their food intake despite energy
requirements; (ii) inactivating NAc-5-HTR4 can reduce and
even suppress the preference for MDMA, as also observed in
5-HTR2B KO mice.
69 Chronic stimulation may desensitize
5-HTR4
70 and has been excluded from our subtasks. None-
theless, increased cAMP production in the NAc71 upon
stimulation of the 5-HTR4 in freely moving mice
14 could
trigger addiction.
In conclusion, motor hyperactivity is anorexia-dependent
upon activation of the NAc-5-HTR4/CART pathway. Probably,
a rewarding effect associated with energy expenditure
(anorexia/hyperactivity) may facilitate to limit excessive
intakes (overeating/resting). Present and previous find-
ings6,14,64,72 bring out at least two modes of action of 5-HT
to regulate feeding. In baseline conditions, feeding may be
regulated via the hypothalamic 5-HTR2C/CART pathway but,
when motivation comes into play, the NAc-5-HTR4/5-HTR1B/
CART pathway might prevail over the autonomic nervous
control of feeding because NAc-5-HTR4/CART surplus makes
the brain ‘silent’ to energy loss. Finally, it is conceivable that an
anorectic-rewarding pathway of the NAc predisposes animals
to a possible dependence on restrictive diet and hyperactivity,
two hallmarks of anorexia nervosa.
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